Obexelimab Antibody
Obexelimab (XmAb5871) is a bifunctional monoclonal antibody targeting CD19 and FcyRIIb, designed to inhibit B-cell lineage activity. It is utilized in preclinical and clinical research for autoimmune conditions like systemic lupus erythematosus, investigating its mechanisms in both cellular assays and animal models.
Product Specifications
Product Name Alternative
XmAb5871, AMG729, AMG 729, Apoptosis, CD19, Immunology related, Immunologyrelated, Inflammation related, Inflammationrelated
Target
Immunology/Inflammation related, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
6.29 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
147.44 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CCDC63, CT (CCDC63, Coiled-coil domain-containing protein 63) (FITC) discontinued